The Epileptic Heart Syndrome: Epidemiology, pathophysiology and clinical detection

Area of Science:

• Cardiology
• Neurology
• Clinical Medicine

Background:

• Population studies indicate a higher incidence of cardiovascular events in individuals with chronic epilepsy.
• Pathophysiological mechanisms include accelerated atherosclerosis, myocardial infarction, autonomic dysfunction, heart failure, arrhythmias, and hyperlipidemia.
• These cardiovascular issues are linked to seizure-induced catecholamine surges and hypoxemic cardiac damage.

Purpose of the Study:

• To propose a unifying concept,
• The Epileptic Heart Syndrome,
• to describe the complex cardiovascular risks in chronic epilepsy patients.
• To outline diagnostic strategies for evaluating cardiac risk in this population.

Main Methods:

• Review of existing literature on cardiovascular complications in epilepsy.
• Analysis of pathophysiological links between epilepsy, seizures, antiseizure medications, and cardiac events.
• Proposal of diagnostic criteria using standard electrocardiography, echocardiography, and lipid panels.

Main Results:

• Chronic epilepsy is associated with multiple cardiovascular risks, including accelerated atherosclerosis and arrhythmias.
• Antiseizure medications can exacerbate heart disease by increasing plasma lipids or causing arrhythmias.
• The proposed diagnostic approach aims to identify at-risk individuals.

Conclusions:

• The constellation of cardiovascular problems in epilepsy patients can be conceptualized as "The Epileptic Heart Syndrome."
• Standard diagnostic tools can aid in identifying this syndrome.
• Early diagnosis and risk stratification are crucial for reducing premature cardiac death in epilepsy patients.